Mr John Beatty
Treatments on the whole are individualised to patients depending on age, prostate size, medical problems, previous surgery and local expertise. Often there is a choice and your specialist will help in the decision-making.
As a general rule low risk patients have a very small risk of dying from prostate cancer 10 years from diagnosis and often a surveillance programme with regular PSA tests and examination is favoured. Curative treatment options are preferred for patients with intermediate and high-risk cancer with a good life expectancy.
The most common curative treatment options available are radiation to the prostate or surgery. Radiation kills the cells in the prostate by burning them and can be given either from outside the body or directly into the prostate (brachytherapy).
Surgery can be performed by an open or keyhole approach. Robotic surgery is the most recent advance in keyhole surgery and gives the surgeon improved vision and dexterity. Another potential curative approach is to try and target a specific area of cancer in the prostate with focal treatment using ultrasound (HIFU) or most recently laser light to destroy cancer cells.
Focal prostate cancer treatment is still evolving and is currently not routinely available.
If prostate cancer has spread, hormones with or without chemotherapy is the most common treatment. In men with shorter life expectancies and localised or locally advanced prostate cancer without symptoms, deferred hormonal treatment may be the best option.
Mr Alan Patrick Doherty
Monitoring, Hormone therapy, Radiotherapy ( including Brachytherapy and Cyberknife), Surgery (including Robotic, laparoscopic and open), or focal therapies (eg HIFU).
Mr Tom Leslie
There are many treatments available and it does depend on what stage the cancer is. The options could include active surveillance, surgery (usually a robot assisted radical prostatectomy with the Da Vinci robot), radiotherapy, focal therapy (treating just part of the prostate using High Intensity Focused Ultrasound), light activated drugs (VTP), or freezing (cryotherapy).For more advanced disease, hormone therapy to hold the cancer back is the most common treatment.